Internal Medicine, Gastroenterology · Quincy, MA
NPI
1740418466
Since 2009
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
500 Congress St Ste 3a
Quincy, MA, 02169
Phone (617) 471-0033
Groups this clinician bills Medicare through
Medicare paid, 2024
$193K
5,879 services
Medicare patients, 2024
281
Average age 72
Drug cost, 2024
$100K
669 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alan C Wong was code 45385 (colonoscopy - lesion removal), 96 times for 96 patients. In total Alan C Wong billed 5,879 services in 66 codes, and Medicare paid $193K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45385 Colonoscopy - Lesion Removal | Office | 96 | 96 | $405.30 | $39K |
| 45380 Lower GI Endoscopy - Other | Office | 88 | 88 | $194.25 | $17K |
| 99214 Office E&M - Established | Office | 53 | 44 | $97.59 | $5,172 |
| 43239 Upper GI Endoscopy | Office | 50 | 47 | $267.73 | $13K |
| 36415 Venipuncture Blood Collection | Office | 45 | 28 | $8.65 | $389 |
| 85027 Blood Count | Office | 40 | 21 | $6.34 | $254 |
| 99213 Office E&M - Established | Office | 33 | 29 | $74.39 | $2,455 |
| 82728 Clinical Chemistry | Office | 26 | 18 | $13.36 | $347 |
| 99204 Office E&M - New | Office | 19 | 19 | $115.05 | $2,186 |
| 99215 Office E&M - Established | Office | 17 | 16 | $155.49 | $2,643 |
| 45385 Colonoscopy - Lesion Removal | Facility | 16 | 16 | $224.25 | $3,588 |
| 82746 Clinical Chemistry | Office | 15 | 15 | $14.41 | $216 |
| 82607 Clinical Chemistry | Office | 15 | 14 | $14.78 | $222 |
| 45380 Lower GI Endoscopy - Other | Facility | 12 | 12 | $68.59 | $823 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Office | 11 | 11 | $324.37 | $3,568 |
By year: 2022 $159K for 3,532 services; 2023 $186K for 4,597 services; 2024 $193K for 5,879 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 45 | 28 | $8.65 | $389 |
| 85027 Blood Count | 40 | 21 | $6.34 | $254 |
| 82728 Clinical Chemistry | 26 | 18 | $13.36 | $347 |
| 82607 Clinical Chemistry | 15 | 14 | $14.78 | $222 |
| 82746 Clinical Chemistry | 15 | 15 | $14.41 | $216 |
Medicare prescription drug claims, 2024
In 2024, the drug Alan C Wong prescribed most often to Medicare patients was Omeprazole, with 166 prescriptions and refills. In total Alan C Wong wrote 669 Medicare prescriptions that cost $100K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 166 | 431 | 56 | $2,294 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 82 | 82 | 79 | $1,499 |
| Peg3350-Sod Sul-Nacl-Kcl-Asb-C Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 72 | 72 | 68 | $4,975 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 64 | 64 | 60 | $4,079 |
| Mesalamine Generic | 40 | 73 | Under 11 | $27K |
| Colestipol Hcl Generic | 35 | 71 | Under 11 | $3,941 |
| Pantoprazole Sodium Generic | 34 | 100 | 16 | $507 |
| Budesonide Dr Budesonide | 18 | 21 | Under 11 | $806 |
| Ondansetron Hcl Generic | 17 | 17 | Under 11 | $22.66 |
| Nortriptyline Hcl Generic | 16 | 41 | Under 11 | $185 |
| Famotidine Generic | 15 | 26 | Under 11 | $78.29 |
| Lansoprazole Generic | 14 | 27 | Under 11 | $744 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 13 | 13 | 12 | $101 |
| Entecavir Generic | 12 | 12 | Under 11 | $800 |
Brand drugs: - claims; generic drugs: 591 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Alan C Wong were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.